This finding is consistent with a dominant-negative effect of the ACC-associated KCTD1 and KCTD15 mutations that result in a loss-of-function effect of both KCTD1 and KCTD15 proteins. This evidence concerns the gene KCTD15 and adrenal cortex carcinoma.